PURPOSE: The enVista Aspire™ (EA) intraocular lens (IOL; Bausch + Lomb) is indicated for the visual correction of aphakia following cataract surgery in adults. By applying higher-order aspheric coefficients to its posterior surface, the EA IOL provides a broaden depth of focus and visual range beyond that of conventional spherical monofocal and low-order aspheric IOLs. The aim of this retrospective, single-surgeon case series was to evaluate initial distance- and intermediate-range visual outcomes and examine the functional benefits of the EA IOL in patients following cataract surgery.

SETTING: This case series includes a single surgeon's experience of implanting the EA IOL from October 14, 2025 to November 26, 2025 at a single site in Hong Kong, China.

METHODS: Patients with poor baseline visual acuity, a monovision-target treatment plan, previous ocular surgery, or other pre-existing ocular conditions were excluded from this case series. Clinical outcomes included corrected distance visual acuity (CDVA), uncorrected distance visual acuity, uncorrected intermediate visual acuity (UIVA), manifest refraction spherical equivalent (MRSE), and safety up to 18-days following the procedure.

RESULTS: The EA IOL was implanted in 13 eyes (OD, n=8; OS, n=5) of 12 patients following cataract extraction. Mean ± standard deviation (SD) age was 71.3 ± 6.4 years, and 75% were female. Mean ± SD pre-operative spherical power and spherical equivalent target were 21.46 ± 3.66 D and −0.04 ± 0.13 D, respectively. At a median (range) follow-up of 8 (6–18) days, mean ± SD monocular CDVA was 0.08 ± 0.07 logMAR, with 76.9% (n=10) of eyes achieving 0.1 logMAR or better and all eyes achieving 0.3 logMAR or better. Mean ± SD monocular UIVA was 0.17 ± 0.08 logMAR, with all eyes achieving 0.3 logMAR or better. Mean ± SD postoperative MRSE was 0.00 ± 0.51 D. No serious adverse events (AEs) were reported, and no photic phenomena were noted.

CONCLUSIONS: This case series highlights the real-world clinical performance and safety of the EA IOL in adults following cataract surgery. The majority of patients achieved good distance and functional intermediate vision, and no serious AEs or photic phenomena were reported. Limitations of this case series include a small sample size and a short follow-up duration; as such, further investigations are warranted to evaluate longer-term visual outcomes of the EA IOL in larger cohorts.